GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Construction In Progress

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Construction In Progress : $22.73 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Construction In Progress?

Ginkgo Bioworks Holdings's quarterly construction in progress increased from Sep. 2023 ($15.10 Mil) to Dec. 2023 ($15.83 Mil) and increased from Dec. 2023 ($15.83 Mil) to Mar. 2024 ($22.73 Mil).

Ginkgo Bioworks Holdings's annual construction in progress increased from Dec. 2021 ($10.28 Mil) to Dec. 2022 ($23.43 Mil) but then declined from Dec. 2022 ($23.43 Mil) to Dec. 2023 ($15.83 Mil).


Ginkgo Bioworks Holdings Construction In Progress Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Construction In Progress Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
- 42.58 10.28 23.43 15.83

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.38 19.83 15.10 15.83 22.73

Ginkgo Bioworks Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.